Other
Interest Expense, Nonoperating
Revolution Medicines, Inc. Interest Expense, Nonoperating increased by 6.7% to $12.20M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026May 6, 2026
How to read this metric
An increase indicates higher debt levels or rising interest rates, which may increase financial risk.
Detailed definition
This represents the cost of servicing the company's debt obligations, excluding any interest income or capitalized inter...
Peer comparison
Standard across all industries; comparable to 'Interest Expense' on the income statement of any debt-financed company.
Metric ID:
other_interest_expense_nonoperatingHistorical Data
8 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $11.43M | $12.20M |
| QoQ Change | — | — | — | — | — | — | — | +6.7% |
Range$0.00 – $12.20M
Interest Expense, Nonoperating at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s interest expense, nonoperating?
- Revolution Medicines, Inc. (RVMD) reported interest expense, nonoperating of $12.20M in Q1 2026.
- What does interest expense, nonoperating mean?
- The cost of interest paid on outstanding debt.